SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $113,071,435 |
| Positions | 25 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| DEFINIUM THERAPEUTICS INC | DFTX | COM SHS | $18,816,000 | 400,000 |
| ABIVAX SA | ABVX | SPONSORED ADS | $16,657,500 | 125,000 |
| MINERVA NEUROSCIENCES INC | NERV | COM NEW | $12,075,701 | 2,175,802 |
| PROMIS NEUROSCIENCES INC | PMN | COM SHS | $8,163,398 | 620,319 |
| FIRST TRACKS BIOTHERAPEUTICS | TRAX | ORD SHS | $5,719,854 | 284,287 |
| AXSOME THERAPEUTICS INC | AXSM | COM | $4,036,992 | 16,493 |
| ASSEMBLY BIOSCIENCES INC | ASMB | COM NEW | $3,847,200 | 140,000 |
| WHITEHAWK THERAPEUTICS INC | WHWK | COM | $3,746,161 | 817,939 |
| EDGEWISE THERAPEUTICS INC | EWTX | COM | $3,384,479 | 83,300 |
| CLIMB BIO INC | CLYM | COM | $3,249,203 | 249,172 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.